Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

31.31
Delayed Data
As of Mar 24
 +0.01 / +0.03%
Today’s Change
25.55
Today|||52-Week Range
35.04
+14.60%
Year-to-Date
Primecap Sells NVIDIA, Microsoft, Union Pacific
Mar 23 / GuruFocus News - Paid Partner Content
AstraZeneca (AZN): Should Value Investors Pick this Stock?
Mar 17 / Zacks.com - Paid Partner Content
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Exp...
Mar 17 / Zacks.com - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
Inovio (INO) Q4 Loss Wider than Expected; Shares Decline
Mar 16 / Zacks.com - Paid Partner Content
Central Bank Shell Game: What Sweden's Negative Interest Rates Do To Consumers
Mar 21 / Investing Channel - Paid Partner Content
AstraZeneca's Cancer Drug Lynparza Positive in Phase III
Mar 15 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar 20 / Zacks.com - Paid Partner Content
Trump vows to bring drug prices 'way down'
Mar 07 / CNNMoney.com